Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)

PHASE2CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

August 31, 2013

Study Completion Date

November 30, 2013

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

BT061

subcutaneous administration of the monoclonal antibody BT061

BIOLOGICAL

Placebo

subcutaneous injection of placebo

Trial Locations (39)

Unknown

Study Site, Ostrava

Study Site, Prague

Study Site, Uherské Hradiste

Study Site, Zlín

Study Site (Berlin 1), Berlin

Study Site (Berlin 2), Berlin

Study Site, Erlangen

Study Site, Frankfurt

Study site, München

Study Site, Nyíregyháza

Study Site, Székesfehérvár

Study Site, Bari

Study Site, Cagliari

Study Site, Chieti

Study Site, Florence

Study Site, Genova

Study site, Milan

Study site, Padua

Study Site, Palermo

Study site, Daugavpils

Study site, Riga

Study Site (Bialystok 2), Bialystok

Study Site, Bialystok

Study Site, Bydgoszcz

Study Site, Elblag

Study site, Gmina Końskie

Study Site, Krakow

Study Site, Lublin

Study Site, Poznan

Study Site, Torun

Study site, Warsaw

Study Site, Wroclaw

Study site (Barcelona 1), Barcelona

Study site (Barcelona 2), Barcelona

Study Site, Bilbao

Study Site (Madrid2), Madrid

Study Site, Madrid

Study Site, Málaga

Study Site, Santander

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biotest

INDUSTRY